Case Study – Symbiosis and The Cell and Gene Therapy Catapult (CGT Catapult)

The manufacture of gene therapy viral vectors (tools used to deliver genetic material into cells) requires specialised, high-quality manufacturing facilities and technologies. Currently, there is insufficient capacity in the UK and globally. In this case study we review the collaboration with Stevenage Cell and Gene Therapy Catapult (CGTC) manufacturing centre and with clinical-stage biotechnology
company Freeline Therapeutics to develop a UK-based supply chain.

Download the case study today to find out more about the highly complex manufacturing capabilities that brought this partnership to life and allowing for greater access to these much needed gene therapy products.